Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

35 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Formyl peptide receptor-1 (FPR1) represses intestinal oncogenesis.
Le Naour J, Montégut L, Pan Y, Scuderi SA, Cordier P, Joseph A, Sauvat A, Iebba V, Paillet J, Ferrere G, Brechard L, Mulot C, Dubourg G, Zitvogel L, Pol JG, Vacchelli E, Puig PL, Kroemer G. Le Naour J, et al. Among authors: scuderi sa. Oncoimmunology. 2023 Jul 21;12(1):2237354. doi: 10.1080/2162402X.2023.2237354. eCollection 2023. Oncoimmunology. 2023. PMID: 37492227 Free PMC article.
A Chemically Defined TLR3 Agonist with Anticancer Activity.
Le Naour J, Thierry S, Scuderi SA, Boucard-Jourdin M, Liu P, Bonnin M, Pan Y, Perret C, Zhao L, Mao M, Renoux C, Pérez-Lanzón M, Martin B, Kepp O, Kroemer G, Werlé B. Le Naour J, et al. Among authors: scuderi sa. Oncoimmunology. 2023 Jun 27;12(1):2227510. doi: 10.1080/2162402X.2023.2227510. eCollection 2023. Oncoimmunology. 2023. PMID: 37389102 Free PMC article.
Correction: Casili et al. Therapeutic Potential of BAY-117082, a Selective NLRP3 Inflammasome Inhibitor, on Metastatic Evolution in Human Oral Squamous Cell Carcinoma (OSCC). Cancers 2023, 15, 2796.
Casili G, Scuderi SA, Lanza M, Filippone A, Mannino D, Giuffrida R, Colarossi C, Mare M, Capra AP, De Gaetano F, Portelli M, Militi A, Cuzzocrea S, Paterniti I, Esposito E. Casili G, et al. Among authors: scuderi sa. Cancers (Basel). 2024 Mar 20;16(6):1211. doi: 10.3390/cancers16061211. Cancers (Basel). 2024. PMID: 38539576 Free PMC article.
Therapeutic Potential of BAY-117082, a Selective NLRP3 Inflammasome Inhibitor, on Metastatic Evolution in Human Oral Squamous Cell Carcinoma (OSCC).
Casili G, Scuderi SA, Lanza M, Filippone A, Mannino D, Giuffrida R, Colarossi C, Mare M, Capra AP, De Gaetano F, Portelli M, Militi A, Cuzzocrea S, Paterniti I, Esposito E. Casili G, et al. Among authors: scuderi sa. Cancers (Basel). 2023 May 17;15(10):2796. doi: 10.3390/cancers15102796. Cancers (Basel). 2023. PMID: 37345134 Free PMC article.
35 results